細胞治療のための方法および組成物

Title:

細胞治療のための方法および組成物

Document Type and Number:

Japanese Patent JP2023546300

Kind Code:

A

Abstract:

本明細書において、１つまたは複数のヒト白血球抗原を含む合成複合体（ｓｙｎＨＬＡ）が提供され、ここで上記複合体は免疫応答を誘発することを阻害される。また、上記複合体をコードする核酸分子、上記複合体または上記核酸分子を含む免疫不全幹細胞、ならびに、上記複合体、上記核酸分子、または上記免疫不全幹細胞を対象に投与する工程を含む疾患または障害を処置する方法が提供される。【選択図】図１０

More Like This:

JP2022536345	Novel interleukin-2 variants for the treatment of cancer
WO/2001/083772	SPLICE VARIANT OF CAMP PHOSPHODIESTERASE TYPE 7 (PDE7A3)
JP2023526770	Recombinant spike protein of novel coronavirus (COVID-19, coronavirus infectious disease 2019) forming a trimer, a method for mass production of the recombinant spike protein in plants, and a method for producing a vaccine composition based thereon (Method for production of novel coronavirus trimeric spike protein in plants and use for vaccination)

Inventors:

waldman, hellman
buckle, ashley
Woolfson, Adrian

Application Number:

JP2023548545A

Publication Date:

November 01, 2023

Filing Date:

October 19, 2021

Export Citation:

Click for automatic bibliography generation Help

Assignee:

Replay Holdings, Inc.

International Classes:

C12N15/62; A61K31/7088; A61K35/12; A61K35/545; A61K38/17; A61K48/00; A61P35/00; A61P37/06; A61P43/00; C07K14/74; C07K19/00; C12N15/12

Attorney, Agent or Firm:

Kiyohara International Patent Office

Previous Patent: Hybrid alphavirus-SARS-COV-2 particles and methods of their production and use

Next Patent: Improving skin permeability of novel peptides by structural modification, chemical enhancers, and mi...